Biosortia Microbiomics provides small molecules and datasets from our deep access to unculturable microbes in microbiomes, a valuable proven source for future therapeutics. Our unique direct access to previously inaccessible microbial small molecules and extensive datasets will accelerate discovery in critical life science areas including new opportunities with next-generation drugs, agrochemicals, longevity, sustainability, advanced energy, and more.

Biosortia Microbiomics was invented and is the only company practicing Microbiome Mining. Our technology, equipment, and processes execute in an environmentally friendly way to find, obtain, process, analyze, and prepare small molecules and datasets for contractual research and collaborative opportunities.

Small molecules, metabolomics datasets, and analytics are obtained from naturally occurring microbiomes with overlapping genes and metabolic pathways of humans and other microbiomes. The source microbiomes are recovered at a scale and quality that permits deep understanding because Biosortia’s exclusive technologies reach at least 6 orders of magnitude beyond traditional methods.